Clinical trials located in

Taufkirchen

Taufkirchen city is located in Germany. Currently, 1 clinical trials are being conducted in this city.

Taufkirchen, located in Bavaria, Germany, is a city rich in history and culture. It is nestled near Munich, offering a blend of traditional charm and modern amenities. The city is known for its beautiful church, St. John the Baptist, which showcases stunning architecture. Taufkirchen also boasts a vibrant community life with various cultural events and festivals throughout the year. The Perlacher Forest, on its doorstep, provides a natural escape for outdoor enthusiasts. Additionally, the city has a strong commitment to sustainability, with numerous initiatives aimed at preserving its natural beauty for future generations.

  • CT-EU-00118673

    Study WVE-003 in patients with early-stage Huntington’s disease

    This clinical trial is a study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of a new drug called WVE-003 in adult patients with early Huntington’s disease (HD). WVE-003 is a type of drug designed to target specific genetic sequences. In this case, it is targeting a single nucleotide polymorphism (SNP), known as SNP3, in Huntington’s disease patients. The drug is administered intrathecally, i.e., it is injected into the spinal canal.

    The study is double-blind, meaning neither patients nor researchers know who is receiving the actual drug and who is receiving the placebo. This helps ensure the results are impartial. The primary goal is to evaluate the safety of WVE-003 by monitoring the percentage of patients who experienced adverse events from day 1 to the end of the study, which lasts a minimum of 36 weeks.

    • WVE-003

See more clinical trials in other cities in Germany:

.